AMGN DMA



As of date:2/21/2024
AMGN stock price:283.46
AMGN 50 DMA:294.27
AMGN 200 DMA:257.00
AMGN MACD (200-50):-37.27

Also see:
AMGN Market Cap History
AMGN Shares Outstanding History
AMGN YTD Return
AMGN RSI
AMGN MACD
AMGN Technical Analysis

Canada Goose Holdings Makes Bullish Cross Above Critical Moving Average
1 hour, 3 minutes ago


Cascades Crosses Below Key Moving Average Level
1 hour, 3 minutes ago


RMR Crosses Below Key Moving Average Level
19 hours, 25 minutes ago


RUN Makes Notable Cross Below Critical Moving Average
19 hours, 25 minutes ago


Bullish Two Hundred Day Moving Average Cross - MAT
19 hours, 33 minutes ago


CIX Makes Notable Cross Below Critical Moving Average
19 hours, 34 minutes ago


QYLD Makes Notable Cross Below Critical Moving Average
19 hours, 36 minutes ago


AL Crosses Below Key Moving Average Level
19 hours, 38 minutes ago


Obsidian Energy Breaks Above 200-Day Moving Average - Bullish for OBE
19 hours, 38 minutes ago


BlackRock Energy and Resources Trust (BGR) Shares Cross Above 200 DMA
19 hours, 39 minutes ago


Silgan Holdings Breaks Above 200-Day Moving Average - Bullish for SLGN
19 hours, 39 minutes ago


Vail Resorts Breaks Above 200-Day Moving Average - Bullish for MTN
19 hours, 39 minutes ago


First Trust Utilities AlphaDEX Fund Breaks Above 200-Day Moving Average - Bullish for FXU
20 hours ago


Enghouse Systems Crosses Below Key Moving Average Level
20 hours, 1 minute ago


Chesapeake Energy (CHK) Shares Cross Above 200 DMA
23 hours, 52 minutes ago


More Technical Analysis News

AMGN DMAAMGN MACD
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

When researching a stock like Amgen, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from AMGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for AMGN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the AMGN 200 day moving average ("AMGN 200 DMA"), while one of the most popular "shorter look-backs" is the AMGN 50 day moving average ("AMGN 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Amgen.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree AMGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amgen (AMGN) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

BAX DMA
BDX DMA
BIIB DMA
BIO DMA
BMY DMA
BSX DMA
CAH DMA
CI DMA
CNC DMA
COO DMA
More Healthcare companies »

 

AMGN DMA | www.StockDMA.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.